Therefore, in our study we aimed: 1) to evaluate if BDNF and IGF-1 serum concentrations separately and in combination might be biomarkers for MDD diagnosis and treatment response; 2) to evaluate the relationships between clinical MDD parameters and serum levels of the above-mentioned neurotrophins. The gene discussed is BDNF; the disease is major depressive disorder.